Anirban Maitra· @Aiims1742 · X·· 2026-04-21Score60
Reading
KRAS / RAS targeting: from platform to Phase 3
daraxonrasib ± GnP · mono ORR 47%; +GnP ORR 55%, DCR 90%
Body
Good morning from #AACR26!
Busy day for
@Perlmutter_CC
@nyulangone
today with multiple presentations & posters.
Looking forward to my own session on #PancreaticCancer.
@salmanpunekar
@MarcusDGon
@NeilVasan
Heat 25 · 20 likes · 1 reply · 4 reposts
Source: Anirban Maitra · x.com